Zvi Shmuel Ben - 01 Jan 2023 Form 3 Insider Report for Vascular Biogenics Ltd.

Reporting relationship: Director
Issuer ticker: N/A
Reported as of: 01 Jan 2023
Net transaction value: $0
SEC form: 3
Accepted by SEC: 03 Jan 2023, 20:03:02 UTC
Prior SEC filing: 09 Sep 2022
Next SEC filing: 03 Oct 2023
Source filing: View source filing
Reporting owner signature: /s/ Samuel Backenroth, Attorney-in-Fact

Key filing fact

Zvi Shmuel Ben filed Form 3 for Vascular Biogenics Ltd. on 03 Jan 2023.

Key facts

This page summarizes Zvi Shmuel Ben's Form 3 filing for Vascular Biogenics Ltd..
0 reported transactions and 6 derivative rows are listed below.
Accepted by SEC: 03 Jan 2023, 20:03.

Change

Previous filing in this sequence was filed on 09 Sep 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

VBLT holding

Ordinary Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 60,000
Date: 01 Jan 2023
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

VBLT holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 01 Jan 2023
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 30,000
Exercise price: $1.78
Footnotes: F1

VBLT holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 01 Jan 2023
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 20,000
Exercise price: $1.22
Footnotes: F1

VBLT holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 01 Jan 2023
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 40,000
Exercise price: $1.22
Footnotes: F2

VBLT holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 01 Jan 2023
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 45,000
Exercise price: $1.22
Footnotes: F3

VBLT holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 01 Jan 2023
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 35,468
Exercise price: $2.31
Footnotes: F4

VBLT holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 01 Jan 2023
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 23,645
Exercise price: $2.12
Footnotes: F5

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

These options were granted under the Issuer's Employee Share Ownership and Option Plan (2014) (the "2014 Plan") and are fully vested and exercisable.

Footnote F2

These options were granted on 12/19/2019 under the 2014 Plan, with 25% of the shares underlying these options vesting on December 19, 2020 (the one year anniversary of the grant date), and the remainder vesting quarterly thereafter for three years such that they are vested in full on the four-year anniversary of the grant date.

Footnote F3

These options were granted on 12/08/2020 under the 2014 Plan, with 25% of the shares underlying these options vesting on December 8, 2021 (the one year anniversary of the grant date), and the remainder vesting quarterly thereafter for three years such that they are vested in full on the four-year anniversary of the grant date.

Footnote F4

These options were granted on 12/07/21 under the 2014 Plan and vest over two years commencing on the grant date such that 50% vest on the first anniversary of the date of grant and the remainder vest quarterly thereafter for one year such that they are vested in full on the two-year anniversary of the grant date.

Footnote F5

These options were granted on 01/02/22 under the 2014 Plan and vest over two years commencing on the grant date such that 50% vest on the first anniversary of the date of grant and the remainder vest quarterly thereafter for one year such that they are vested in full on the two-year anniversary of the grant date.

SEC remarks

Exhibit 24 - Power of Attorney

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .